openPR Logo
Press release

Veterinary Anti Infectives Market Is Driven By An Increasing Dependency On Telemedicine At A CAGR Of 4.1%

06-28-2022 06:13 PM CET | Health & Medicine

Press release from: Persistence Market Research

Veterinary Anti Infectives Market Is Driven By An Increasing

In recent years, reports of deadly animal disease outbreaks have become more recurrent. These diseases are not only a threat to the existence of many wild species but also lead to substantial livestock losses.

The prevention and treatment of such diseases are key market indicators for veterinary therapeutics including veterinary anti-infectives. In its latest report, Persistence Market Research has projected that the global veterinary anti-infectives market will expand at a CAGR of 4.1% over the forecast period (2017-2025) and reach a valuation of US$ 5,221.2 Mn by 2025-end.

Get Going With Sample Of Veterinary Anti Infectives Market Report!

Company Profiles

Bayer AG
Cipla Limited
Dechra Pharmaceuticals PLC
Eli Lilly and Company (Elanco Animal Health)
Heska Corp (Diamond Animal Health)
Merck & Co., Inc. (Merck Animal Health)
Neogen Corporation
Phibro Animal Health Corporation
Sanofi (Merial Animal Health)
Vetoquinol S.A.
Virbac S.A.
Zoetis, Inc.
Boehringer Ingelheim GmbH
Ceva Santé Animale
Indian Immunologicals Limited
Intas Pharmaceuticals Limited
Norbrook Laboratories Limited
Zydus Animal Health Limited
Ashish Life Science Private Limited
Oceanic Pharmachem Private Limited.

How About Re-Inventing The Methodical Wheel In The Veterinary Anti Infectives Market? Switch Over To The "Methodology" Tab!

Increasing demand for anti-microbial agents is expected to contribute significantly towards the growth of market revenue in the near future. The rise in livestock population can boost the demand for veterinary therapeutics globally.

In 2014, the Food and Agriculture Organization of the United Nations estimated the global cattle count at over 1.5 billion. These figures are further expected to grow substantially due to rapidly growing demand for livestock.

North America to Remain the Frontrunner in the Global Veterinary Anti-Infective Market

North America is currently the largest veterinary anti-infectives market and is estimated to represent 30.5% value share of the global market by 2025-end, expanding at CAGR of 3.7%.

This growth is primarily attributed to the increase in pet ownership and demand for high-quality meat in the U.S. and Canada. Meanwhile, Latin America will continue to be the second most attractive market during the forecast period. The market in Asia Pacific (APAC) is projected to witness the fastest growth over 2025.

Keeping A Tab On Key Players In The Veterinary Anti Infectives Market? Go To "Purchase Now" To Decipher The Competitive Analysis In Our Veterinary Anti Infectives Market Report!

Additional Highlights of the Report Include:

Based on species types, use of veterinary anti-infectives medicines is relatively higher on livestock animals as compared to pet animals. In 2016, livestock animals accounted for more than 68% market value share, however, this figure is likely to drop to 67.4% by 2025 end.

Antimicrobial agents currently are the most preferred drug type. By the end of forecast period, antimicrobial agents are expected to command for 54.6% value share of the market. Other drugs such as antifungal agents and antiviral agents are also gaining traction owing to product improvement and effectiveness.

Based on modes of administration, the oral route is presently the most common drug administration mode followed by the parenteral route. By the end of 2025, the oral administration segment is projected to reach a market valuation of US$ 1,573.1 Mn.

Veterinary clinics are projected to reaming the leading distribution channel for veterinary anti-infectives in 2017 and beyond. Of late, veterinary hospitals and pharmacies have emerged as the other two key distribution channels for various veterinary drugs including anti-infectives.

Access PMR Exclusive Reports-

CCTV Camera Market-

Computer Accessories Market-

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Veterinary Anti Infectives Market Is Driven By An Increasing Dependency On Telemedicine At A CAGR Of 4.1% here

News-ID: 2665481 • Views: 167

More Releases from Persistence Market Research

Quality Stuff To Be Bestowed Upon Through Augmented Reality And Virtual Reality …
"The global sterile injectable drugs market will potentially achieve the revenues worth US$ 657 Bn by the end of 2024. With a compound annual growth rate of more than 7%, the market is expected to experience promising growth prospects over an eight-year forecast period, 2016-2024." - Persistence Market Research In a recently published report outlook titled "Sterile Injectable Drugs Market: Global Industry Analysis and Forecast, 2016-2024," Persistence market Research
The Cryotherapy Market To Witness Digitized Dispersion Of Products/Services
According to a study conducted by Persistence Market Research (PMR), the global market for cryotherapy is set to witness a CAGR of 6.5% during the forecast period 2016-2024. According to the study, North America will continue to be the leading market for cryotherapy globally during the forecast period. Highlights from the Report Suppliers are emphasizing on ensuring affordable and adequate supply of gas in order to provide smoother maintenance services to clients,
The Medtech Industry To Give Impetus To The Life Science Market
According to a study conducted by Persistence Market Research (PMR) on the global market for life science products, incessant progress in the field of biotech science has led to the development of various new-age and consumer-friendly life science products in recent years. The PMR study reveals that the global life science products market is set to witness a CAGR of over 4% in terms of revenue between 2016 -2024. The
The Crohns Disease Treatment Market To Tilt Towards Digital Therapeutics
The Crohn's & Colitis Foundation of America (CCFA) stated that over 1 Million Americans were diagnosed with Crohn's & ulcerative colitis disorders, with most of them aged above 30. Growing occurrence of Crohn's disease has triggered a robust demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has revealed that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new

All 5 Releases